Drug Topics
MAY 30, 2024
Chris DesRochers, a pharmacy technician who works at a CVS in Wakefield, Rhode Island and is active in the recent organizing, discusses what motivated him and his coworkers to unionize.
STAT
MAY 30, 2024
A third human case of H5 bird flu tied to the ongoing U.S. outbreak in cattle has been detected in a farm worker in Michigan, state health authorities confirmed on Thursday. The unnamed individual worked on a dairy farm and was in close contact with infected cows, the state health department said in a statement. The farm involved is different from the one where an earlier human case was detected last week.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MAY 30, 2024
The approval of Lisocabtagene maraleucel (Breyanzi; liso-cel) was based on data from the TRANSCEND-NHL-001 study, in which the therapy showed rapid and durable response rates.
Pharmacy Times
MAY 30, 2024
Tune into this special episode of “Public Health Matters” to hear Emma White, the founder and president of the nonprofit organization Life Is Worth It, discuss her mental health journey and how she used it to educate adolescents, teenagers, and young adults on mental wellness.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
MAY 30, 2024
The drug will be available in pharmacies during the second half of 2024.
Fierce Healthcare
MAY 30, 2024
WASHINGTON D.C. — CVS Health continues to invest heavily in healthcare delivery services with a focus on affordability, convenience and better access to primary care. | CVS Health continues to make investments in healthcare delivery services with a focus on affordability, convenience and better access to primary care.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Outsourcing Pharma
MAY 30, 2024
In an intriguing interview with Cybinâs CEO, Doug Drysdale, OSP senior editor, Liza Laws found out how second-generation psychedelics could be the biggest breakthrough in psychiatry in 40 years.
STAT
MAY 30, 2024
Most physicians who endorsed a prescription drug or medical device on X — formerly known as Twitter — also received payments from the manufacturers of these products, according to a new analysis that highlights ongoing concerns about financial ties between doctors and industry. The study found 26 of 28 physicians, or 93%, received at least one payment, and the average was more than $27,400 for such things as food and beverages, speaking, consulting, or travel.
Fierce Healthcare
MAY 30, 2024
UnitedHealth is predicting an upcoming “disturbance” among its Medicaid programs as members continue to disenroll after the COVID-19 public health emergency. | UnitedHealth gave an overview of areas in which the insurer can improve upon, how Medicaid redeterminations will affect the company and thoughts on OptumRx.
pharmaphorum
MAY 30, 2024
COVID-19 vaccination rates have fallen precipitously in Europe and should be ramped up this autumn so they are at least in line with influenza vaccine uptake.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
MAY 30, 2024
Lenora Newsome, PD, president of the National Association of Boards of Pharmacy, explores how pharmacists can support mental health through private conversations, and educating about prescriptions.
pharmaphorum
MAY 30, 2024
Discover how genomics is transforming cancer research through the study of DNA, RNA, and ctDNA. Learn about the latest breakthroughs in the field in this insightful short read.
Pharmacy Times
MAY 30, 2024
Although resources were scarce for teams at smaller private practices, the pharmacists all agreed that patient care is always the priority.
Fierce Pharma
MAY 30, 2024
As various efforts to produce next-generation vaccines in Africa are being carried forward by the likes of the World Health Organization (WHO) and the Bill & Melinda Gates Foundation, BioNTech | Under an expansion of the partners’ existing deal, the Coalition for Epidemic Preparedness Innovations (CEPI) is committing up to $145 million to bolster BioNTech’s efforts to establish vaccine R&D and manufacturing capabilities at the German company’s facility in Kigali, Rwanda.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
MAY 30, 2024
Lisocabtagene maraleucel (Breyanzi; Bristol Myers Squibb) is a CD19-directed CAR T cell therapy that is delivered as a 1-time infusion.
PharmD Live
MAY 30, 2024
Polypharmacy, or the concurrent use of at least five medications, can be essential for individuals with multiple chronic conditions. When medications are prescribed with clear therapeutic objectives, optimized to minimize adverse drug reactions (ADRs), and the patient adheres to the regimen, polypharmacy can be appropriate and beneficial. However, it often becomes excessive and hazardous when medications are unnecessary, fail to meet therapeutic goals, pose a high risk of ADRs, or when the patie
Fierce Healthcare
MAY 30, 2024
The feds have raised an objection about Steward Health Care's planned bankruptcy proceedings, seeking additional time to investigate the health system's planned sale of its assets. | The feds have raised an objection about Steward Health Care's planned bankruptcy proceedings, seeking additional time to investigate the health system's planned sale of its assets.
Pharmacy Times
MAY 30, 2024
There has been a general shift toward earlier treatment and less tolerance for clinically silent disease activity.
STAT
MAY 30, 2024
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox. There is now a drug on the U.S. market, approved this week, called Bkemv. I’m not kidding. I wish I were. I’m flying to Chicago today for the ASCO meeting.
Pharmacy Times
MAY 30, 2024
Individuals from a lower socioeconomic group showed more benefits from low-dose CT screening relating to lung cancer survival.
Fierce Pharma
MAY 30, 2024
The United States Department of Health and Human Services has expanded its avian flu pandemic preparedness partnership with CSL Seqirus, lining up the vaccine specialist to
PharmaVoice
MAY 30, 2024
To lower drug prices, lawmakers are turning to the drug patent system to outlaw some common practices — but a former patent agency director says it’s the wrong way to go.
pharmaphorum
MAY 30, 2024
The US Congress has passed the first-ever federal bill dedicated to ending Parkinson’s disease, modelled on similar legislation for Alzheimer’s enacted in 2011
Fierce Pharma
MAY 30, 2024
In the span of half a year, Gilead Sciences' Trodelvy has flopped a second phase 3 trial. | Following a high-profile lung cancer setback in January, Gilead said Thursday that Trodelvy also failed to move the needle in a bladder cancer study. The flop threatens the ADC's accelerated approval in the tumor type.
STAT
MAY 30, 2024
WASHINGTON — Nearly 20 years ago, policymakers had an epiphany: The health care system should pay for value instead of volume. Unfortunately, it’s now less clear than ever what value-based payment means, and whatever it is, it hasn’t lived up to the hype. Value-based payment, also known as value-based care, is getting renewed attention in Congress as doctors become increasingly distressed by a Medicare pay system that does not keep up with inflation.
Fierce Healthcare
MAY 30, 2024
Highmark Health is echoing macro trends reported by other major insurers, as the company posted $7.3 billion in revenue and $194 million in net income for the first quarter. | Highmark Health recorded $7.3 billion in revenue for the first quarter but said the company is not immune to greater environmental pressures.
The Checkup by Singlecare
MAY 30, 2024
Hydroxyzine is an antihistamine that is used to treat allergies, allergic reactions, and anxiety disorders. Side effects are a common concern when starting a new medication, especially if it’s one you need every day to avoid allergy symptoms or manage your mental health. After all, weight gain is a known possible side effect of antihistamines and most antidepressants.
Fierce Pharma
MAY 30, 2024
In the years since gaining an initial FDA approval for Breyanzi, Bristol Myers Squibb has worked hard to expand the reach of its cell therapy. | In the years since gaining an initial FDA approval for Breyanzi, Bristol Myers Squibb has worked hard to expand the reach of its cell therapy. For the third time in as many months, those efforts have yielded a label expansion at the FDA.
Drug Topics
MAY 30, 2024
Catch up on important continuous glucose monitoring (CGM) news from the month of May.
Fierce Pharma
MAY 30, 2024
With a target date for FDA approval less than a month away, Sanofi and Regeneron’s megablockbuster Dupixent has gained much attention as it is on the verge of becoming the first biologic to treat c | With Verona Pharmaceuticals' COPD candidate ensifentrine approaching its FDA decision date, GlobalData has referred to it as a “paradigm shift in COPD treatment.
Pharmacy Times
MAY 30, 2024
Tools provide a safer testing option without using the viral proteins that cause infection.
Outsourcing Pharma
MAY 30, 2024
In a bold move set to reshape the global healthcare landscape, Asahi Kasei Corp. announced its intent to acquire Swedish drug maker Calliditas Therapeutics AB through a voluntary tender offer.
Pharmacy Times
MAY 30, 2024
A review of asthma guidelines, pharmacotherapy, and the role of the pharmacist.
European Pharmaceutical Review
MAY 30, 2024
A novel drug delivery method combining proline and metal such as palladium, could enable chemotherapy drugs to be transported in the body via nano-sized cages. Practically, this could enable delivering the structure “more directly” to a tumour, while “shielding healthy cells”. Chemotherapy drugs, antibiotics, as well as antivirals could be transported using this delivery system , the authors theorised.
Expert insights. Personalized for you.
212 
Let's personalize your content